RxDoctor Payments Data

Ferial Walid, MD

Family Medicine · Warner Robins, GANPI 1750486742

Payments from drug & device makers

$1,116in general payments, 2019–2025

Across 10 payments — averaging $111.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Welch Allyn$643
  • AstraZeneca$182
  • E.r. Squibb & Sons, L.L.C.$125
  • Medtronic$103
  • Lilly USA, LLC$27
  • Amgen$20
  • plus $17 from 1 others

What the payments were for

  • Food & beverage$47342%
  • Other$64358%

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Welch Allyn1$643
AstraZeneca(2 entities)3$182
E.r. Squibb & Sons, L.L.C.1$125
Medtronic1$103
Lilly USA, LLC2$27
Amgen1$20
Abbott1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,116 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$79,193
Medicare patients
137
Services billed
776

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide26$42,266
OzempicSemaglutide34$34,649
EliquisApixaban16$27,151
JanumetSitagliptin Phos/Metformin Hcl17$17,450
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$10,837
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$3,126
Rosuvastatin Calcium110$2,001
Ezetimibe36$1,831
Albuterol Sulfate HfaAlbuterol Sulfate25$1,160
Levothyroxine Sodium114$1,123
Nano 2nd Gen Pen NeedlePen Needle, Diabetic12$1,073
Hydralazine Hcl87$1,047
Esomeprazole Magnesium20$1,045
Cyclobenzaprine Hcl48$935
Losartan Potassium115$801

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$27$42,26626 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Warner Robins

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →